Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$69.73 - $142.9 $697,300 - $1.43 Million
-10,000 Closed
0 $0
Q4 2021

Jan 31, 2022

SELL
$134.56 - $217.97 $134,560 - $217,970
-1,000 Reduced 9.09%
10,000 $1.43 Million
Q3 2021

Oct 28, 2021

SELL
$177.8 - $270.58 $181,533 - $276,262
-1,021 Reduced 8.49%
11,000 $2.28 Million
Q2 2021

Jul 21, 2021

SELL
$121.0 - $257.67 $82,159 - $174,957
-679 Reduced 5.35%
12,021 $2.55 Million
Q1 2021

Apr 14, 2021

SELL
$112.98 - $319.93 $372,834 - $1.06 Million
-3,300 Reduced 20.63%
12,700 $2.3 Million
Q3 2020

Nov 10, 2020

BUY
$79.44 - $178.51 $1.27 Million - $2.86 Million
16,000 New
16,000 $1.73 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Advisors Management Group Inc Portfolio

Follow Advisors Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Advisors Management Group Inc with notifications on news.